Ram Kamineni active positions
| Companies | Position | Start | End |
|---|---|---|---|
| KRYSTAL BIOTECH, INC. | Chief Tech/Sci/R&D Officer | 2022-06-30 | - |
Career history of Ram Kamineni
Former positions of Ram Kamineni
| Companies | Position | Start | End |
|---|---|---|---|
KVK-Tech, Inc.
 KVK-Tech, Inc. Pharmaceuticals: MajorHealth Technology KVK-Tech, Inc. is a pharmaceutical company based in the United States, specifically in Newtown, PA. The private company specializes in the development and manufacture of high-quality, FDA-approved medicines that address unmet patient needs. KVK-Tech handles all aspects of the manufacturing process, including packaging, distribution, research and development, and customer service. The company's portfolio includes a range of generic drugs that are chemically identical to branded drugs and must meet the same strict standards to receive FDA approval. KVK-Tech has a vision for 2020 to manufacture high-quality, affordable generics in every major dosage form. The CEO of the company is Anthony Tabasso. | Chief Operating Officer | 2021-03-31 | 2021-09-30 |
Statistics
International
| United States | 3 |
Operational
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| KRYSTAL BIOTECH, INC. | Health Technology |
| Private companies | 1 |
|---|---|
KVK-Tech, Inc.
KVK-Tech, Inc. Pharmaceuticals: MajorHealth Technology KVK-Tech, Inc. is a pharmaceutical company based in the United States, specifically in Newtown, PA. The private company specializes in the development and manufacture of high-quality, FDA-approved medicines that address unmet patient needs. KVK-Tech handles all aspects of the manufacturing process, including packaging, distribution, research and development, and customer service. The company's portfolio includes a range of generic drugs that are chemically identical to branded drugs and must meet the same strict standards to receive FDA approval. KVK-Tech has a vision for 2020 to manufacture high-quality, affordable generics in every major dosage form. The CEO of the company is Anthony Tabasso. | Health Technology |
- Stock Market
- Insiders
- Ram Kamineni
- Experience
